This technique successfully discovered neutrophil-driven interferon (INF)-inducible blood transcriptional signature for active Tuberculosis that involved both INF- and type I IFN-α/β signaling, which was later verified in multiple countries [20]. Here, CBLIF is linked to tuberculosis.